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Aims. To undertake a systematic review of the recent (2008–2013) primary literature, describing views and experiences of CAM
use during pregnancy by women and healthcare professionals. Method. Medline, Cumulative Index to Nursing and Allied Health
Literature, Cochrane Database of Systematic Review Library and Allied, and Complementary Medicine Database were searched.
Studies reporting systemic CAM products (homeopathic preparations, herbal medicines, Vitamins and minerals, homeopathy,
and special diets) alone or in combination with other nonsystemic CAM modalities (e.g., acupuncture) were included. Results.
Database searches retrieved 2,549 citations. Removal of duplicates followed by review of titles and abstracts yielded 32 relevant
studies. Twenty-two reported the perspectives of women and their CAM use during pregnancy, while 10 focused on healthcare
professionals.Themajority of studies had significant flaws in study design and reporting, including a lack of appropriate definitions
of CAM and associated modalities, absence of detailed checklists provided to participants, the use of convenience sampling, and a
general lack of scientific robustness in terms of data validity and reliability. Conclusion. To permit generalisability of study findings,
there is an urgent need to expand the evidence base assessing CAMs use during pregnancy using appropriately designed studies.
1. Introduction
TheWorld Health Organisation defines “complementary and
alternative medicine” (CAM) as a “broad set of health care
practices that are not part of that country’s own tradition and
are not integrated into the dominant health care system” [1].
However the scope of CAM is broad and various including
therapies such as acupuncture, aromatherapy, herbal, and
homeopathic medicines [2]. Whist acknowledging limita-
tions of the published literature (varying definitions of CAM,
bias, and confounding), studies undertaken throughout the
world have reported women to be large consumers of CAM
with prevalence figures of with 56–88% of UK women [3],
over 50% of middle aged and older Australian women [4],
and over 90% of menopausal Canadian women [5]. Unlike
conventional licensed medicines, few CAM approaches to
healthcare are supported by robust efficacy, effectiveness,
or safety data [6, 7], which raises potential concerns about
the use of CAM, particularly in high risk patients such as
pregnant women where teratogenicity is a concern [8].
Several limited literature reviews have focused on the
use of CAMs by pregnant women [9–11] and recommen-
dations for use by health professionals during pregnancy
[9, 12]. While these reviews have concentrated on the
findings of relevant CAM-based studies, they have placed
less emphasis on critically appraising the core elements
of study design and reporting. Limited reviews of CAM
recommendations made by healthcare professionals report
that CAMapproaches, particularly herbal therapy, chiroprac-
tic, acupuncture/acupressure, massage, homoeopathy, and
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aromatherapy are commonly recommended and used in the
maternity setting.
We report a systematic review of the primary literature
published over the last five years (2008–2012) focusing on
the views and experiences of CAM use during pregnancy by
women and healthcare professionals, with emphasis on study
design and limitations of findings.
2. Method
2.1. Search Strategy. A systematic review protocol was pre-
pared as per standard guidelines [13, 14]. The databases
Medline, Cumulative Index to Nursing and Allied Health
Literature (CINAHL), Cochrane Database of Systematic
Review (CDSR) library, and Allied and Complementary
Medicine Database (AMED) were searched from January
2008 to December 2012 inclusive, using the search terms (as
keywords, title, and abstract) of pregnancy, complementary,
alternative, herbal, homeopathic, vitaminmidwife, obstetri-
cian, doctor, physician, woman, patient, views, opinions,
experiences, and prevalence. Wildcard symbols, truncation,
combinations of search terms using Boolean operators, and
alterative spellings were used. Included studies reported
either women and/or healthcare professionals’ perspectives
of prevalence and outcomes of CAM use. Studies reporting
systemic CAM products (homeopathic preparations, herbal
medicines, vitamins and minerals, homeopathy, and special
diets) either alone or in combination with other nonsys-
temic CAM modalities (e.g., acupuncture) were included.
The reference lists from identified papers were scanned for
other relevant studies. The search was limited to English
language articles. Studies published only as abstracts, letters,
or conference proceedings were excluded.
Initial screening of titles was carried out to identify
potentially relevant studies, followed by screening of abstracts
and then by full paper review. Fifty titles and abstracts were
independently evaluated by two reviewers for consistency of
inclusion/exclusion.
2.2. Study Review and Data Extraction. Independent quality
assessments were conducted by two independent review-
ers utilising standard criteria for critical appraisal [15, 16]
(Table 1).
Data extracted were; country of study, CAM definitions
and scope, sample size and response rate, prevalence of use,
perceived effectiveness and safety, and predictors of CAM
use. Due to lack of study homogeneity, a narrative synthesis
of the results was conducted.
3. Results
Database searches retrieved 2,549 citations. Removal of
duplicates followed by review of titles and abstracts yielded 32
relevant studies. The PRISMA flowchart (Figure 1) illustrates
the number of titles, abstracts, and full papers excluded.
Twenty-two studies reported the perspectives of women
and their CAM use during pregnancy, while 10 focused on
healthcare professionals.
Table 1: Criteria for critical appraisal.
(1) Is a definition of CAMs/herbals given?
(2) Is a description of CAMs/herbals checklist given?
(3) Is the information about the ethics given (approved/not
required)?
(4) Are study inclusion and exclusion criteria fully described?
(5) Is the sample size fully justified?
(6) Is development of questionnaire (validity, reliability, and piloting)
fully described?
(7) Are study strengths and limitations fully discussed?
(8) Is generalisability fully discussed?
Cochrane database 
of systematic 
reviews (n = 0)
Medline, CINAHL, 
AMED (n = 2549)∗
For title screening 
(n = 2549)
Excluded (n = 2475)
Abstract screening 
(n = 74)
For full text screening
(n = 32)
Excluded (n = 42)
Excluded (n = 2)
Bibliography of 
included literature 
for full text screening 
(n = 2)
Included in the review 
(n = 30)
Total included (n = 32)
Figure 1: PRISMA flowchart, ∗after removal of duplicates.
Included studies were conducted in Europe (𝑛 = 13), the
Americas (𝑛 = 8), Asia (𝑛 = 6), Australia and Oceania (𝑛 =
4), and Africa (𝑛 = 1). Data were collected by questionnaire
(𝑛 = 21) or structured interview (𝑛 = 11). Findings of
the critical appraisal are reported in Table 2 and Figure 2.
Summaries of study details are provided in Table 3 (women)
andTable 4 (health professionals). Data should be interpreted
with caution due to inconsistency and lack of CAMandCAM
related definitions, limitations of study design, and a paucity
of outcomes data.
3.1. Studies Assessing Experience and Views of Women (𝑛 =
22). Eleven of the 22 studies reported on more than one
CAMmodality, nine focused on herbals only and two studies
reported herbals, and vitamins.
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16
20
18
7
6
3
6
14
16
12
7
3
26
21
5
12
7
22
8
21
6
Is a definition of CAM/herbal given?
Is a description of CAM/herbal checklist given?
Is information about the ethical review/study approval given?
Are study inclusion and exclusion fully described?
Is  the sample size fully  justified?
Is development of questionnaire (validity, reliability, piloting) fully described?
Are study strengths and limitations  fully discussed?
Is generalisability  fully discussed?
Yes
No
Unclear/partly
Figure 2: Stacked bar chart representing quality assessment of reviewed studies (𝑛 = 32).
3.1.1. Definitions and Scope. Of the 11 studies reporting data
for more than one CAM modality, only four [20, 28, 31,
38] defined the term “CAM”. Five of these 11 studies [17,
18, 28, 31, 38] provided a detailed and specific checklist
of CAM modalities and products to research participants.
However, the content and specificity of these checklists were
highly variable, precluding direct interstudy comparisons.
For example, Adams et al. [17] listed
“vitamins or minerals, yoga/meditation, herbal
medicines, aromatherapy oils, and Chinese medi-
cines”
while Bishop et al. [18] included
“treatments, pills, medicines, ointments, homeo-
pathic medicines, herbal medicines, supplements,
drinks, and herbal teas”.
No information on study CAM checklists was provided
in the remaining six studies [19–21, 24, 27, 30].
Of the nine studies assessing only herbals use, eight pro-
vided a definition of herbal medicine [22, 23, 25, 32, 33, 35–
37]. However, no consistent definitionwas used. For example,
Tabatabaee [23] defined “herbal drugs” as
“all types of products (oral and dermatological)
that were manufactured from herbs or contained
herbs as the major component”
while Holst et al. [35] defined “herbal remedies” as
“any kind of product such as a tablet, amixture, an
ointment or herbal teas which are produced from
plants and used to acquire better health”.
Only five of these nine studies detailed the specific
checklist of herbals provided to research participants [22, 26,
35–37]. The content of these checklists varied greatly listing
between nine and 40 products, with a free text option to
permit participants to add unlisted herbal products.
3.1.2. Study Design. Only two of the 22 studies assessing
the experiences and views of women [18, 19] used the ideal
prospective, longitudinal study design, collecting data at
several time points during pregnancy and following delivery.
However, while Al-Riyami et al. [19] collected data 3 months
prior to pregnancy and at each trimester, the study reported
by Bishop et al. [18] had a 20-year gap between data collection
(1991-1992) and study publication in 2011 raising significant
concerns around current validity of data.
The remaining 20 studies reported collection of retro-
spective data, thus introducing potential recall bias with
implications for data validity and reliability. For example,
participants in the study reported by Moussally et al. were
required to recall herbal products used during pregnancy up
to eight years previously [36].
Sample size varied greatly amongst these 22 studies, with
participant numbers varying between 139 and 14,541. Only
six studies [19, 24, 31, 33, 34, 37] described a sample size
calculation detailing estimates of data precision, confidence
intervals, and likely response rates; calculated sample sizes
varied from 122 to 600.
The majority of studies used a convenience approach
for participant sampling and recruitment, which reduces
external validity of the findings. Response rates for ques-
tionnaire studies ranged from 39.0 to 99.0%. Two studies
attempted to demonstrate homogeneity between respondents
and nonrespondents [22, 36]. However, Moussally et al. [36]
reported similarity of respondents and nonrespondents in
terms ofmaternal age, gestational age, rate of hospitalisations,
pre-natal visits, and comorbidities while Nordeng et al. [22]
reported the similarity between respondents and the general
Norwegian postnatal population in terms of frequencies of
age, parity, and marital status.
3.1.3. Study Findings. Notwithstanding limitations of study
design and reporting, it is evident that a significant propor-
tion of women use CAM during pregnancy (see Table 3).
Prevalence rates ranged from 5.8% of 4,866 respondents in
USA taking herbal or natural treatments [30] to 74.2% of 461
Hispanic women in the USA taking herbals [27]. Only nine
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Table 3: Data extraction relating to studies of women (𝑛 = 22).
Authors, year,
country
CAM studied
Stage of
pregnancy at
point of data
collection
Mode of data
collection
Response rate
(RR, %)
Prevalence in pregnancy
Adams et al.,
2011 [17],
Australia
CAM Pregnant Questionnaire 897 (RR notgiven)
81% used vitamins and minerals,
16% aromatherapy, and 15% herbal
medicines.
All significantly higher than
nonpregnant women (𝑃 < 0.001).
No data on stage of pregnancy.
Bishop et al.,
2011 [18], UK CAM
Antenatal
(weeks 8, 12,
18, 32)
Questionnaire
Total response
of 14,115/14,541
(97.1) but varied
at each point of
data collection
26.7% used a CAM at least once.
Most commonly herbal teas (17.7%),
homeopathy (14.4%), and herbal
medicines (5.8%).
Prevalence increased each trimester
(6%, 12.4%, 26.5%, no P values).
Al-Riyami et al.,
2011 [19], Oman CAM
Antenatal
(prenatal,
trimesters 1,
2, 3)
Interview
139 but varied at
each data
collection point
Compared to prenatal, vitamin used
increased from 12% to 84–95%
across three semesters (𝑃 < 0.001),
herbal medicines from 7% to
16–19% (𝑃 < 0.05).
Kalder et al.,
2011 [20],
Germany
CAM Postnatal Questionnaire 205/475 (43.2)
50.7% used CAM (including CAM
practices). Homeopathy (18.5%),
aromatherapy (4.4%).
No data on stage of pregnancy.
Khresheh, 2011
[21], Jordan
CAM used in
treatment of
nausea and
vomiting
Currently
pregnant or
at least one
full term
pregnancy
Questionnaire 235/290 (81.0) 9.4% used herbal medicines.No data on stage of pregnancy.
Nordeng et al.,
2011 [22],
Norway
Herbal Postnatal,within 5 days Interview 600
39.7% used herbal medicines, 4.3%
homeopathy.
No data on stage of pregnancy.
Tabatabaee, 2011
[23], Iran Herbal
Postnatal, 2
days Interview 513
30.8% used herbal medicines.
Tended to be used more in first
trimester (no P values).
Bercaw et al.,
2010 [24], USA
Herbal and
vitamins
Postnatal,
immediately Questionnaire
485 Hispanic
women (RR not
given)
19% used herbal medicines, 47%
vitamins.
No data on stage of pregnancy.
Broussard et al.,
2010 [25], USA Herbal
Postnatal, 6
weeks–2
years Interview 4239
9.4% used herbal medicines, the
highest for first trimester (6.4% v 5.1
and 5.2%) (no P values).
Cuzzolin and
Benoni, 2009
[26], Italy
Herbal Postnatal,within 3 days Interview 392
27.8% used one or more herbal
medicines. Prevalence increased
slightly with trimester (no details or
P values).
Kochhar et al.,
2010 [27], USA Herbal Not stated Questionnaire
461 Hispanic
women (RR not
given)
74.2% used herbal medicines.
No data on stage of pregnancy.
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Table 3: Continued.
Authors, year,
country
CAM studied
Stage of
pregnancy at
point of data
collection
Mode of data
collection
Response rate
(RR, %)
Prevalence in pregnancy
Lapi et al., 2010
[28], Italy CAM
Antenatal,
trimester 3 Interview 150
48% used CAM.
No data on stage of pregnancy.
Leppee et al.,
2010 [29],
Crotia, Serbia
Vitamins,
minerals and
iron
Antenatal Interview 6,992
56.6% used vitamins and minerals
in Croatia, 20.3% in Serbia.
Prevalence increased with trimester
(no details or P values).
Louik et al., 2010
[30], USA
Herbal or
natural
treatments
Postnatal,
within 6
months
Interview 4,866
5.8% used herbal or natural
treatments.
No data on stage of pregnancy.
Mohamed et al.,
2010 [31], Qatar CAM Antenatal Interview 393
67.5% used CAM in first trimester,
37.7% in second, and 28.9% in third
(no P values). Mainly herbal
medicines and food supplements.
Chuang et al.,
2009 [32],
Taiwan
Chinese
herbal Postnatal Interview 21,248
33.6% used Chinese herbal
medicines.
No data on stage of pregnancy.
Fakeye et al.,
2009 [33],
Nigeria
Herbal Antenatal Questionnaire 560/600 (99.0)
67.5% used herbal medicines.
No data on stage of pregnancy.
Forster et al.,
2009 [34],
Australia
Folic acid and
other vitamin
supplements
Antenatal,
∼38 weeks Questionnaire 588/705 (83.4)
91% took at least one vitamin
supplement (mainly folic acid)
during pregnancy.
Almost all commenced during
trimester 1.
Holst et al., 2009
[35], UK Herbal
Antenatal,
more than 20
weeks
Questionnaire 578/1,037 (55.7) 57.8% used herbal medicines.No data on stage of pregnancy.
Moussally et al.,
2009 [36],
Canada
Herbal
Postnatal,
3–8 years
after birth
Questionnaire 3,354/8,505(39.0)
9% used herbal medicines.
No data on stage of pregnancy.
Rahman et al.,
2009 [37],
Malaysia
Herbal Postnatal Interview 210
52.4% used herbal medicines.
Majority of use was in trimester 3
(no P values).
Skouteris et al.,
2008 [38],
Australia
CAM Antenatal,24–31 weeks Questionnaire
321 (RR not
given)
73.2% used at least one CAM,
mostly massage (49.5%), and
vitamins/minerals (49.5%).
No data on stage of pregnancy.
of the 22 studies linked CAM usage to pregnancy trimester
[18, 19, 23, 25, 26, 29, 31, 34, 37]. Five of these nine studies
[18, 19, 26, 29, 37] reported increased use during the later
stages of pregnancy, while three studies reported decreased
use during pregnancy with the highest use during the first
trimester [23, 25, 31]. Forster et al. reported insufficient data
to draw any conclusions [34].
While 18 of the 22 studies [18, 20–28, 30–32, 34–38]
quantified potential predictors of CAM use during preg-
nancy, only nine used a multivariate approach to analysis
[20, 25, 28, 30, 32, 34–37]. Independent predictors for CAM
use derived from these nine studies included CAM use prior
to pregnancy [20, 28, 35], higher educational attainment
[25, 26, 29], chronic disease/meds [28, 32, 36], ethnic back-
ground/nationality [21, 28], higher income [21], and age [35].
A further major limitation of all 22 studies is the general
lack of data on outcomes of perceived effectiveness, safety and
overall satisfactionwith treatment.While six studies included
measures of effectiveness, none provided objective outcome
data linked to specific CAM modalities, indications, and
trimester of pregnancy. However, in these six studies, respon-
dents’ perceptions of effectiveness were generally positive,
particularly in comparison with conventional approaches.
Mohamed et al. reported that 56.2% of pregnant women
thought that CAM was “more efficacious” and while 62.7%
of pregnant women in the study by Lapi et al reported “equal
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Table 4: Data extraction relating to studies of professionals (𝑛 = 10).
Authors year,
country
Professional
group
CAMs studied
(authors’ terms)
Mode of data
collection
Response rate
(RR, %)
Prevalence
(% recommending for patients)
Koc et al., 2012
[39], Turkey Midwives CAM Questionnaire 129/159 (81.1)
58.9% used CAM in their practice,
mostly herbal medicines, diets, and
exercises (32.6%, 27.9%, and 28.7%).
Dennehy et al.,
2010 [40], USA Midwives
Herbal
medicines Questionnaire
139/460
(30.2)
66.9% used herbal medicines in
their practice.
Hrgovic et al., 2010
[41], Croatia
Heads of
obstetrics CAM Questionnaire 36/36 (100)
Homeopathy, aromatherapy,
massage, moxibustion,
phytotherapy, acupressure,
reflexology, and Reiki were not used
at all (no data on herbal).
Acupuncture used at two centres
only.
Samuels et al., 2010
[42], Israel Midwives CAM Questionnaire 173/238 (72.7)
70% used CAM in their practice
(49.1% massage, 37.0% herbals, and
33.5% homeopathy).
Harding and
Foureur, 2009 [43],
New Zealand,
Canada
Midwives CAM Questionnaire 343/648(52.9)
71.95% recommended or offered
CAM often (31%), very frequently
(28%) or always (13%). Most
common homeopathy, followed by
herbal medicines, aromatherapy,
and acupuncture (given as
frequencies for different patient
numbers, e.g., 50% of midwives
recommend for 70–100% of their
patients).
Hastings-Tolsm
and Terada, 2009
[44], USA
Midwives CAM Questionnaire 227/500(45.0)
78% used CAM in their practice
mostly herbal medicines (85%),
pharmacologic/biologic treatments
(82%), and mind-body
interventions (80%).
Mu¨nstedt et al.,
2009 [45],
Germany
Heads of
obstetrics CAM Questionnaire 138/187 (73.4)
100% offered acupuncture, 95.7%
homoeopathy, and 50.7%
aromatherapy. Decisions to provide
CAM were largely made by
midwives.
Mu¨nstedt et al.,
2009 [46],
Germany
Head of
obstetrics CAM Questionnaire
381/946
(40.3)
97.3% offered acupuncture, 93.4%
homeopathy, and 76.6%
aromatherapy. Decisions to provide
CAM were largely made by
midwives.
Wiebelitz et al.,
2009 [47],
Germany
Midwives
(lecturers,
students)
CAM Questionnaire 309/309 (100)
63.1% estimated CAM to be
“applied frequently” (defined as
>25% of their pregnant patients) by
midwives. 50–75% estimated
homeopathy used “regularly”,
20–40% phytotherapy, and 28-27%
hydrotherapy.
Furlow et al., 2008
[48], USA
Obstetric,
gynaecology
physicians
CAM Questionnaire 401/1,009(41.0)
97.6% routinely endorsed, provided
or referred patients for at least one
CAMmodality. 86.4% movement
therapies, 80.3% biofeedback etc.
61.4% herbal, and 41.7%
homeopathy.
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effectiveness” [28, 31]. In terms of herbals, Cuzzolin noted
that 74.3% of respondents considered these to be “beneficial,
reporting good results”, with similar figures reported by Rah-
man et al. and Fakeye et al. Skouteris et al. commented that
almost all (97.3%) users of natural remedies “got completely
better” or “got a bit better” [26, 33, 37, 38].
Only five studies assessed and reported the potential for
possible CAM-related adverse effects (AE’s) during preg-
nancy; however, both intra- and inter-study results were
conflicting. While just over half of the respondents in two
studies [28, 31] viewed CAM approaches to be safer than
traditional medicine, the majority had concerns about the
safety of herbals. Kochhar et al. reported that 67.7% of
respondents agreed that herbals could harm a baby if taken
during pregnancy, and Bercaw et al. reported that a minority
of respondents (22%) agreed that herbals were safer to use
than prescribed medicines [24, 27]. Similarly, Fakeye et al.
reported that 33.4% of respondents believed that herbals
possessed no AEs [33]. Although three of these studies
did report observed AEs, none provided precise details of
the method used for AE identification (specific tick list or
open comments). Fakeye et al. reported that 18% of those
taking herbals had “some form of unwanted effects” such as
vomiting, and dizziness. Cuzzolin and Benoni and Leppee et
al. both reported that 3.7% of respondents experienced mild
AEs [26, 29, 33].
Only one study (Kalder et al.) reported on overall user
satisfaction with treatment. The authors limited their report
to that “almost all respondents were satisfied” [20].
3.2. Studies Assessing Experience and Views of Healthcare
Professionals (𝑛 = 10). Of the ten studies, nine reported data
on more than one CAMmodality and one on herbals only.
3.2.1. Definitions and Scope. Of the nine studies reporting
data for more than one CAM modality, only four [39, 42,
43, 48] defined “CAM” while eight provided a detailed and
specific checklist of CAMmodalities and products. Dennehy
et al. focused on herbals but neither defined “herbals” nor
described a specific checklist [40].
3.2.2. Study Design. Questionnaires were used in all ten
studies, with sample sizes varying from 36 (heads of obstetric
departments in Croatia) [41] to 1,009 (obstetric gynaecology
physicians in USA) [48]. All ten studies used a convenience
approach to participant sampling and recruitment with sub-
sequent limitation of external validity of findings. Response
rates ranged from 30.2% [40] to 100% [41, 47]; all those with
response rates less than 100% did not consider homogeneity
of respondents and nonrespondents.
3.2.3. Study Findings. Six studies [39, 40, 42–44, 47] assessed
the views and experiences of midwives while the remaining
four studies focused on obstetricians [41, 45, 46, 48]. Despite
limitations of study design and reporting, most respondents
(other than heads of obstetric departments in Germany) [41]
used CAMs in their practice.
Issues of perceived effectiveness or safety of CAMs were
quantified in two studies. Koc et al. reported that 61.2% of
midwife respondents in Turkey thought that CAM would
be “beneficial”, 24.9% that CAM use decreased pregnancy-
related complaints, and 61.2% that CAM use may have AEs
[39]. In a study of obstetric physicians in USA, Furlow et al.
reported that more than 50% of respondents had positive
beliefs on the effectiveness of biofeedback, chiropractic,
acupuncture, and meditation whereas 41.2% and 24.9% had
positive views on herbals and homeopathic preparations,
respectively [48]. Importantly, while the study by Harding
and Foureur did not report objective measures of effective-
ness or safety of CAM, this study did report that 71.0%
of midwife respondents in the USA viewed CAM to be an
“essential part of midwifery practice” [43].
4. Discussion
Despite a lack of evidence for efficacy and safety, CAM use is
reportedly increasing worldwide. Of possible concern is the
use of CAM modalities, such as herbals, in high risk patient
groups such as pregnantwomen.The results of this systematic
review of the recent published literature highlight the high
levels of systemic CAM use, by women and healthcare pro-
fessionals, during pregnancy.
However, it is clear that the majority of studies assessing
CAM use during pregnancy have limitations in terms of both
study design and reporting. Specific weaknesses were a lack
of appropriate definitions of CAM and associated modalities,
the absence of detailed checklists provided to research partic-
ipants, the frequent use of convenience sampling, and limited
detail of considerations of face and content of questionnaire
items and test-retest reliability. For these reasons, it was
not possible to pool the data from identified studies in an
appropriate way to generate meaningful and generalisable
conclusions.
Our systematic review was conducted according to best
practice as defined by the Centre for Reviews andDissemina-
tion [13]. Of note each paper was independently reviewed by
two authors using standard evidence-based critical appraisal
criteria [14]. To ensure that this review was current we are
restricted to peer reviewed reports of primary data published
during the last five years.
The application of a consistent and useable CAM defini-
tion proved to be amajor issue.While CAMhas been defined
by theWHO [1], this definition is vague and open to multiple
interpretations, particularly interpretation of “tradition” and
“healthcare systems”. Indeed, whether or not a particular
therapy is deemed to be CAM may differ between countries,
healthcare settings, and specialities. This situation could
readily be overcome by the use of standardised, validated
checklists. In those studies where checklists were issued
to participants, the list of CAM products and modalities
included varied widely leading to potentially significant
differences in participant product identification. Without a
clear and specific definition of each CAM modality and
CAM products, it is impossible to perform study comparison
or pool data for the purposes of meta-analysis. The lack
of definitions and checklists may explain why the reported
prevalence of CAM use appears to be highly variable, even
within similar populations.
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Furthermore, the majority of studies reviewed employed
a retrospective method of data collection, with the subse-
quent limitation of recall bias. The ideal study design which
in the case of pregnant women should be prospective and
longitudinal, collecting data both before and throughout the
course of pregnancy and preferably following delivery should
be given consideration in future studies. This would reduce
the inherent effects of recall bias and furthermore would
permit linkage of CAM use with indication, trimester of
pregnancy, and outcome.
Most studies relied on single centre data collection using
a convenience approach to sampling. While this may be jus-
tified in terms of study logistics, there are clear implications
for external validity. Furthermore, a sample size calculation
was rarely reported and presenting lacked full statistical jus-
tification, thus having implications for confidence in reported
outcomes.
While inferential statistics were employed, there was
often a lack of multivariate approaches, which may be one of
the reasons for the conflicting results and conclusions in rela-
tion to factors influencing the use ofCAMsduring pregnancy.
There is a need to expand the evidence base assessing
CAMs use during pregnancy in terms of prevalence with
emphasis on outcomes of effectiveness and potential AEs.
Efficacy studies are required for those modalities and pro-
ducts widely used by women during pregnancy and those
recommended by healthcare professionals. In addition, qual-
itative exploration of the reasons for use, factors affecting use,
and position of CAMs within the overall treatment hierarchy
is warranted.
Study Highlights
(i) Reportedly CAM’s are widely used by women during
pregnancy.
(ii) What is the quality of recent published evidence
reporting the views, experiences of pregnant women
and healthcare professionals towards CAM use dur-
ing pregnancy?
(iii) The quality of the published literature is limited in
terms of both study design and reporting.
(iv) There is an urgent need to expand the research based
on CAM use in pregnancy. Appropriately designed
efficacy studies are required for those CAM modal-
ities and products widely used.
Conflict of Interests
The authors do not have any issues of involvement, financial,
conflict or otherwise that might potentially bias his or her
work.
Authors’ Contribution
James S. McLay, Derek Stewart, Abdul Rouf Pallivalappila,
Ashalatha Shetty, and Binita Pande designed the review. All
authors contributed to phases of data collection, synthesis,
writing, and reviewing the paper.
References
[1] WorldHealthOrganisation, TraditionalMedicines: Definitions,
2013, http://www.who.int/medicines/areas/traditional/defini-
tions/en/index.html.
[2] E. Ernst, M. H. Pittler, and B. Wider, The Desktop Guide
to Complementary and Alternative Medicine, Mosby Elsevier,
Amsterdam, The Netherlands, 2006.
[3] K. J. Hunt, H. F. Coelho, B. Wider et al., “Complementary and
alternativemedicine use in England: results from a national sur-
vey,” International Journal of Clinical Practice, vol. 64, no. 11, pp.
1496–1502, 2010.
[4] J. Sarris, T. B. R. Wahlin, D. C. Goncalves, and G. J. Byrne,
“Comparative use of complementary medicine, allied health,
and manual therapies by middle-aged and older Australian
women,” Journal of Women & Aging, vol. 22, no. 4, pp. 273–282,
2010.
[5] C. A. Lunny and S. N. Fraser, “The use of complementary and
alternative medicines among a sample of Canadian menopaus-
al-aged women,” Journal of Midwifery & Women’s Health, vol.
55, no. 4, pp. 335–343, 2010.
[6] C. S. Broussard, C. Louik, M. A. Honein, and A. A. Mitchell,
“Herbal use before and during pregnancy,” American Journal of
Obstetrics & Gynecology, vol. 202, no. 5, pp. 443.e1–443.e6, 2010.
[7] A. Fugh-Berman and F. Kronenberg, “Complementary and
alternative medicine (CAM) in reproductive-age women: a
review of randomized controlled trials,” Reproductive Toxicol-
ogy, vol. 17, no. 2, pp. 137–152, 2003.
[8] D. M. Marcus andW. R. Snodgrass, “Do no harm: avoidance of
herbal medicines during pregnancy,” Obstetrics & Gynecology,
vol. 105, no. 5, part 1, pp. 1119–1122, 2005.
[9] J. Adams, D. Sibbritt, A. Broom et al., “Women’s use of comple-
mentary and alternative medicine during pregnancy: a critical
review of the literature,” Birth, vol. 36, no. 3, pp. 237–245, 2009.
[10] H. G. Hall, D. L. Griffiths, and L. G.McKenna, “The use of com-
plementary and alternative medicine by pregnant women: a
literature review,”Midwifery, vol. 27, no. 6, pp. 817–824, 2011.
[11] A. Steel, J. Adams, and D. Sibbritt, “Complementary and alter-
native medicine in pregnancy: a systematic review,” Journal of
the Australian Traditional-Medicine Society, vol. 17, no. 4, p. 205,
2012.
[12] H. G. Hall, L. G. McKenna, and D. L. Griffiths, “Midwives’ sup-
port for complementary and alternative medicine: a literature
review,”Women and Birth, vol. 25, no. 1, pp. 4–12, 2012.
[13] Systematic Reviews: CRD’s guidance for undertaking reviews
in health care, 2009, http://www.york.ac.uk/inst/crd/SysRev/
!SSL!/WebHelp/SysRev3.htm.
[14] Scottish Intercollegiate Guidelines Network. Search filters, 2011,
http://www.sign.ac.uk/methodology/filters.html.
[15] J. P. Vandenbroucke, E. von Elm, D. G. Altman et al., “Strength-
ening the reporting of observational studies in epidemiology
(STROBE): explanation and elaboration,” Gaceta Sanitaria, vol.
23, no. 2, pp. 158.e1–158.e28, 2009.
[16] F. J. Fowler Jr., Survey Research Methods, vol. 1, Sage Publica-
tions, 2008.
[17] J. Adams, D. Sibbritt, and C.W. Lui, “The use of complementary
and alternative medicine during pregnancy: a longitudinal
study of Australian women,” Birth, vol. 38, no. 3, pp. 200–206,
2011.
[18] J. L. Bishop, K. Northstone, J. R. Green, and E. A. Thompson,
“The use of complementary and alternative medicine in preg-
nancy: data from the Avon Longitudinal Study of Parents and
10 Evidence-Based Complementary and Alternative Medicine
Children (ALSPAC),” Complementary Therapies in Medicine,
vol. 19, no. 6, pp. 303–310, 2011.
[19] I. M. Al-Riyami, I. Q. Al-Busaidy, and I. S. Al-Zakwani, “Med-
ication use during pregnancy in Omani women,” International
Journal of Clinical Pharmacy, vol. 33, no. 4, pp. 634–641, 2011.
[20] M. Kalder, K. Knoblauch, I. Hrgovic, and K. Mu¨nstedt, “Use of
complementary and alternativemedicine during pregnancy and
delivery,” Archives of Gynecology and Obstetrics, vol. 283, no. 3,
pp. 475–482, 2011.
[21] R. Khresheh, “How women manage nausea and vomiting dur-
ing pregnancy: a Jordanian study,” Midwifery, vol. 27, no. 1, pp.
42–45, 2011.
[22] H. Nordeng, K. Bayne, G. C. Havnen, and B. S. Paulsen, “Use of
herbal drugs during pregnancy among 600 Norwegian women
in relation to concurrent use of conventional drugs and preg-
nancy outcome,” Complementary Therapies in Clinical Practice,
vol. 17, no. 3, pp. 147–151, 2011.
[23] M. Tabatabaee, “Use of herbal medicine among pregnant
women referring to Valiasr hospital in Kazeroon, Fars, South
of Iran,” Journal of Medicinal Plants, vol. 10, no. 37, pp. 96–108,
2011.
[24] J. Bercaw, B. Maheshwari, and H. Sangi-Haghpeykar, “The use
during pregnancy of prescription, over-the-counter, and alter-
native medications among Hispanic women,” Birth, vol. 37, no.
3, pp. 211–218, 2010.
[25] C. S. Broussard, C. Louik, M. A. Honein et al., “Herbal use
before and during pregnancy,” American Journal of Obstetrics
& Gynecology, vol. 202, no. 5, pp. 443.e1–443.e6, 2010.
[26] L. Cuzzolin and G. Benoni, “Safety issues of phytomedicines in
pregnancy and paediatrics,” in Herbal Drugs: Ethnomedicine to
Modern Medicine, K. G. Ramawat, Ed., pp. 381–396, Springer,
Berlin, Germany, 2009.
[27] K. Kochhar, R. M. Saywell Jr., T. W. Zollinger et al., “Herbal
remedy use among hispanic women during pregnancy and
while breastfeeding: are physicians informed?”Hispanic Health
Care International, vol. 8, no. 2, pp. 93–106, 2010.
[28] F. Lapi, A. Vannacci, M. Moschini et al., “Use, attitudes and
knowledge of complementary and alternative drugs (CADs)
among pregnant women: a preliminary survey in tuscany,” Evi-
dence-Based Complementary and Alternative Medicine, vol. 7,
no. 4, pp. 477–486, 2010.
[29] M. Leppee, J. Culig, M. Eric, J. Boskovic, and N. Colak, “Vita-
min, mineral and iron supplementation in pregnancy: cross-
sectional study,”Biopolymers and Cell, vol. 26, no. 2, pp. 128–135,
2010.
[30] C. Louik, P. Gardiner, K. Kelley, and A. A. Mitchell, “Use of
herbal treatments in pregnancy,” American Journal of Obstetrics
& Gynecology, vol. 202, no. 5, pp. 439.e1–439.e10, 2010.
[31] H. Mohamed, J. Abdin, and D. Al Kozaai, “Knowledge, atti-
tude and practice of complementary and alternative medicine
(CAM) among pregnant women: a preliminary survey in
Qatar,”Middle East Journal of Family Medicine, vol. 7, no. 10, pp.
5–14, 2010.
[32] C. H. Chuang, P. J. Chang, W. S. Hsieh et al., “Chinese herbal
medicine use in Taiwan during pregnancy and the postpartum
period: a population-based cohort study,” International Journal
of Nursing Studies, vol. 46, no. 6, pp. 787–795, 2009.
[33] T.O. Fakeye, R.Adisa, and I. E.Musa, “Attitude anduse of herbal
medicines among pregnant women in Nigeria,” BMC Comple-
mentary and Alternative Medicine, vol. 9, article 53, 2009.
[34] D. A. Forster, G. Wills, A. Denning, and M. Bolger, “The use of
folic acid and other vitamins before and during pregnancy in a
group of women in Melbourne, Australia,” Midwifery, vol. 25,
no. 2, pp. 134–146, 2009.
[35] L. Holst, D. Wright, H. Nordeng, and S. Haavik, “Use of
herbal preparations during pregnancy: focus group discussion
among expectant mothers attending a hospital antenatal clinic
in Norwich, UK,” ComplementaryTherapies in Clinical Practice,
vol. 15, no. 4, pp. 225–229, 2009.
[36] K. Moussally, D. Oraichi, and A. Be´rard, “Herbal products use
during pregnancy: prevalence and predictors,” Pharmacoepi-
demiology and Drug Safety, vol. 18, no. 6, pp. 454–461, 2009.
[37] A. A. Rahman, S. A. Sulaiman, Z. Ahmad, H. Salleh, W. N. W.
Daud, and A. M. Hamid, “Women’s attitude and sociodemo-
graphic characteristics influencing usage of herbal medicines
during pregnancy in Tumpat District, Kelantan,” Southeast
Asian Journal of Tropical Medicine and Public Health, vol. 40,
no. 2, pp. 330–337, 2009.
[38] H. Skouteris, E. H. Wertheim, S. Rallis et al., “Use of comple-
mentary and alternative medicines by a sample of Australian
women during pregnancy,”Australian andNewZealand Journal
of Obstetrics and Gynaecology, vol. 48, no. 4, pp. 384–390, 2008.
[39] Z. Koc, S. Topatan, and Z. Saglam, “Use of and attitudes toward
complementary and alternative medicine among midwives in
Turkey,” European Journal of Obstetrics Gynecology and Repro-
ductive Biology, vol. 160, no. 2, pp. 131–136, 2012.
[40] C. Dennehy, C. Tsourounis, L. Bui, and T. L. King, “The use of
herbs byCaliforniaMidwives,” Journal of Obstetric, Gynecologic,
and Neonatal Nursing, vol. 39, no. 6, pp. 684–693, 2010.
[41] I. Hrgovic, Z. Hrgovic, D. Habek, S. Oreskovic, J. Hofmann, and
K. Mu¨nstedt, “Use of complementary and alternative medicine
in departments of obstetrics in Croatia and a comparison to
Germany,” Forschende Komplementarmedizin, vol. 17, no. 3, pp.
144–146, 2010.
[42] N. Samuels, R. Y. Zisk-Rony, S. R. Singer et al., “Use of and atti-
tudes toward complementary and alternative medicine among
nurse-midwives in Israel,” American Journal of Obstetrics &
Gynecology, vol. 203, no. 4, pp. 341.e1–341.e7, 2010.
[43] D. Harding and M. Foureur, “New Zealand and Canadian
midwives’ use of complementary and alternative medicine,”
NewZealandCollege ofMidwives Journal, vol. 40, pp. 7–12, 2009.
[44] M.Hastings-Tolsma andM. Terada, “Complementarymedicine
use by nurse midwives in the U.S,” ComplementaryTherapies in
Clinical Practice, vol. 15, no. 4, pp. 212–219, 2009.
[45] K. Mu¨nstedt, C. Schro¨ter, D. Bru¨ggmann, H. R. Tinneberg,
and R. von Georgi, “Use of complementary and alternative
medicine in departments of obstetrics in Germany,” Forschende
Komplementarmedizin, vol. 16, no. 2, pp. 111–116, 2009.
[46] K. Mu¨nstedt, A. Brenken, and M. Kalder, “Clinical indications
and perceived effectiveness of complementary and alternative
medicine in departments of obstetrics in Germany: a ques-
tionnaire study,” European Journal of Obstetrics Gynecology and
Reproductive Biology, vol. 146, no. 1, pp. 50–54, 2009.
[47] K. R. Wiebelitz, T. W. Goecke, J. Brach, and A. M. Beer, “Use of
complementary and alternative medicine in obstetrics,” British
Journal of Midwifery, vol. 17, no. 3, pp. 169–175, 2009.
[48] M. L. Furlow, D. A. Patel, A. Sen, and J. R. Liu, “Physician and
patient attitudes towards complementary and alternative medi-
cine in obstetrics and gynecology,” BMC Complementary and
Alternative Medicine, vol. 8, article 35, 2008.
